3,4-<wbr/>DHMA (trifluoro<wbr/>acetate salt)

3,4-DHMA (trifluoroacetate salt)

CAT N°: 10515

3,4-Dihydroxymethamphetamine (3,4-DHMA) is a catecholamine derived from the metabolism of 3,4-methylenedioxymethamphetamine (MDMA) by debrisoquine hydroxylase.{20867,20864} DHMA can be subsequently O-methylenated by catechol-O-methyltransferase to produce 4-hydroxy-3-methoxymethamphetamine or be glucuronidated prior to excretion.{20864} DHMA, unlike MDMA, is relatively ineffective at stimulating hypothalamic vasopressin or oxytocin release or directing serotonergic neurotoxicity.{20865,20866} This product is intended for forensic or research purposes.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • 4-(2-(methylamino)propyl)benzene-1,2-diol 2,2,2-trifluoroacetate
  • Correlated keywords
    • 438625-59-3 15398-87-5 MDMA metabolism amphetamines forensics ecstasy CYP2D6 COMT HMMA catecholamine hypothalamic vasopressin oxytocin serotonergic neurotoxicity trifluoroacetate salts ecstasy analytical references standards
  • Product Overview:
    3,4-Dihydroxymethamphetamine (3,4-DHMA) is a catecholamine derived from the metabolism of 3,4-methylenedioxymethamphetamine (MDMA) by debrisoquine hydroxylase.{20867,20864} DHMA can be subsequently O-methylenated by catechol-O-methyltransferase to produce 4-hydroxy-3-methoxymethamphetamine or be glucuronidated prior to excretion.{20864} DHMA, unlike MDMA, is relatively ineffective at stimulating hypothalamic vasopressin or oxytocin release or directing serotonergic neurotoxicity.{20865,20866} This product is intended for forensic or research purposes.

We also advise you